COMP <GO>
INMD vs CNMD // GROSS PROFIT MARGIN
InMode Ltd. (NASDAQ) VS. CONMED Corporation (NYSE) • 15-METRIC TALLY: INMD 5
— CNMD 6
▲ GROSS PROFIT MARGIN LEADER: INMD
LAST: $13.51 (+1.05%) • MKT CAP: $776.6M
gross-margins
78.50%
LAST: $45.72 (-0.09%) • MKT CAP: $1.36B
gross-margins
54.60%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (INMD VS. CNMD)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | INMD | CNMD | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | 78.50% | 54.60% | +23.90 | INMD | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 17.70% | 7.80% | +9.90 | INMD | /roic <GO> |
| EV/EBITDA & P/E Valuation | 5.5x | 11.4x | -5.90 | INMD | /valuation <GO> |
| Free Cash Flow Yield | 10.85% | 11.07% | -0.22 | CNMD | /fcf-yield <GO> |
| Operating Margin | 23.00% | 7.50% | +15.50 | INMD | /operating-margins <GO> |
| Net Profit Margin | — | 3.40% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | -6.20% | 5.20% | -11.40 | CNMD | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 1.82% | -1.82 | CNMD | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 9.20 | 1.91 | +7.29 | INMD | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 7/9 | -3.00 | CNMD | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 36.3 | 47.1 | -10.80 | CNMD | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 26.9x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $776.6M | $1.36B | -$586.0M | CNMD | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | INMD REV | CNMD REV | INMD GROSS % | CNMD GROSS % | INMD FCF | CNMD FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $370.5M | $1.37B | 78.5% | 54.6% | $84.3M | $150.9M |
| FY 2024 | $394.8M | $1.31B | 80.3% | 56.1% | $132.0M | $153.9M |
| FY 2023 | $492.0M | $1.24B | — | — | $176.8M | $125.3M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
INMD // BETA —
CNMD // BETA —